Mounjaro Tirzepatide Injections for Weight Loss in Apple Valley, CA and Victorville, CA

In combination with diet and exercise, Mounjaro improves blood glucose control in adults with type 2 diabetes and helps them lose weight. There has been evidence that this dual agonist has powerful effects on managing diabetes and obesity in a number of ways.

Mounjaro acts as a dual GIP and GLP-1 receptor agonist in beta and alpha cells in the pancreas. When blood glucose levels are high, beta cells release insulin, while when blood glucose levels are low, alpha cells release glucagon. With Mounjaro, beta and alpha cells are both regulated by GIP and GLP-1, natural hormones.

The new injectable medication Mounjaro (tirzepatide) is used to treat type 2 diabetes. Tirzepatide injections can also be used for weight loss. Once weekly, tirzepatide is administered subcutaneously at a dosage of 2.5 mg. The dosage may be increased up to 15 mg once weekly in 2.5 mg increments after 4 weeks.

As with other GLP-1 family drugs, Mounjaro contains a GIP receptor agonist in addition to a GLP-1 receptor agonist. By mimicking two incretin hormones produced by the human body, it works by regulating blood sugar levels.

As a hormone, GIP complements the effects of GLP-1 receptor agonists. The effects of GIP on body weight, glucose, and lipids have been shown to be greater when combined with GLP-1 receptor agonism in preclinical models. It has been shown to decrease food intake and increase energy expenditure, resulting in weight reductions.

The release of incretin hormones occurs whenever food is consumed. By delaying gastric emptying and activating satiety centers in the brain, they help promote a feeling of fullness. As well as boosting insulin production, they suppress glucagon production, both of which help normalize blood sugar levels. Due to the fact that all of these reactions occur in a glucose-dependent manner, incretin hormones—or their imitations, such as GLP-1 and GIP receptor agonists—are unlikely to produce severe hypoglycemia.

From reproductive function to memory and mood, excess weight compromises almost every aspect of health. Debilitating and deadly diseases associated with obesity include diabetes, heart disease, and certain types of cancer. A variety of mechanisms contribute to this, some as simple as mechanical stress caused by additional weight, while others involve changes in hormones and metabolism. Individuals’ health and quality of life are negatively affected by obesity, as are the world’s healthcare costs and systems.

Mounjaro is a GLP-1 drug that helps you lose weight and stick to healthy habits, but it does not cause weight loss by itself. If you want to sustain your body weight reduction, you must use GLP-1 or dual GIP/GLP-1 drugs with other strategies that support metabolic health. Among these tactics are dietary changes, exercise modifications, and other healthy lifestyle changes.

Researchers have found that tirzepatide, a once-weekly injectable drug approved to treat type 2 diabetes, could also provide significant weight loss benefits to people who are obese. Among overweight or obese people without type 2 diabetes, the highest dose of the drug, Mounjaro, reduced weight by nearly 21 percent.

When Dr. Shima Hadidchi and her medical team determine that Mounjaro or another GLP-1 is the right fit for you, they will explain dosage, how to administer the medication, when to take it, and how it will work with your metabolic reset. When it comes to treating weight loss, medication such as Mounjaro is just one part of the process.

Dr. Shima Hadidchi will work with patients to establish a comprehensive weight loss management plan including realistic goals, diet, exercise, and medication as needed. If you are interested in Mounjaro tirzepatide injections for weight loss, contact Dr. Shima Hadidchi to find out if this treatment option is right for you. We serve patients from Victorville CA, Apple Valley CA, Adelanto CA, Hesperia CA, Crestline CA, Highland CA, Barstow CA, and BEYOND!